Loading…

In vitro assessment of halobacterial gas vesicles as aChlamydiavaccine display and delivery system

Highlights * Gas vesicles (Gv) displayChlamydiaproteins as part of their membrane structures. * Recombinant gas vesicles (r-Gv) are readily recognized by human immune sera. * Gv engage TLRs and stimulate proinflammatory cytokines in a peptide-specific manner. * Temporal degradation of Gv in vitro, c...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2012-09, Vol.30 (41), p.5942
Main Authors: Childs, Tawanna S, Webley, Wilmore C
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 41
container_start_page 5942
container_title Vaccine
container_volume 30
creator Childs, Tawanna S
Webley, Wilmore C
description Highlights * Gas vesicles (Gv) displayChlamydiaproteins as part of their membrane structures. * Recombinant gas vesicles (r-Gv) are readily recognized by human immune sera. * Gv engage TLRs and stimulate proinflammatory cytokines in a peptide-specific manner. * Temporal degradation of Gv in vitro, culminates in antigen display at cell surface. * R-Gv promise to be an ideal multisubunit vaccine display/delivery platform.
doi_str_mv 10.1016/j.vaccine.2012.07.038
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1625874290</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3500158261</sourcerecordid><originalsourceid>FETCH-proquest_journals_16258742903</originalsourceid><addsrcrecordid>eNqNjctqwzAQAEVpoO7jEwoLPdtdyc-cQ0t7z6G3sLE3iYwspVrF4L9vDvmAnuYwA6PUq8ZCo27ex2KmvreeC4PaFNgWWHZ3KtNdW-am1t29ytA0VV5p_HlQjyIjItalXmdq_-1htikGIBEWmdgnCAc4kQt76hNHSw6OJDCz2N6xXEOgzcnRtAyWbmcYrJwdLUB-gIGdnTkuIIsknp7V6kBO-OXGJ_X2-bHdfOXnGH4vLGk3hkv0V7XTjam7tjJrLP9X_QE2Lk84</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1625874290</pqid></control><display><type>article</type><title>In vitro assessment of halobacterial gas vesicles as aChlamydiavaccine display and delivery system</title><source>ScienceDirect Journals</source><creator>Childs, Tawanna S ; Webley, Wilmore C</creator><creatorcontrib>Childs, Tawanna S ; Webley, Wilmore C</creatorcontrib><description>Highlights * Gas vesicles (Gv) displayChlamydiaproteins as part of their membrane structures. * Recombinant gas vesicles (r-Gv) are readily recognized by human immune sera. * Gv engage TLRs and stimulate proinflammatory cytokines in a peptide-specific manner. * Temporal degradation of Gv in vitro, culminates in antigen display at cell surface. * R-Gv promise to be an ideal multisubunit vaccine display/delivery platform.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2012.07.038</identifier><language>eng</language><publisher>Kidlington: Elsevier Limited</publisher><subject>Antibiotics ; Antigens ; Cloning ; Cytokines ; Deoxyribonucleic acid ; DNA ; Gases ; Infections ; Laboratories ; Peptides ; Plasmids ; Proteins ; Sexually transmitted diseases ; STD</subject><ispartof>Vaccine, 2012-09, Vol.30 (41), p.5942</ispartof><rights>Copyright Elsevier Limited Sep 7, 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Childs, Tawanna S</creatorcontrib><creatorcontrib>Webley, Wilmore C</creatorcontrib><title>In vitro assessment of halobacterial gas vesicles as aChlamydiavaccine display and delivery system</title><title>Vaccine</title><description>Highlights * Gas vesicles (Gv) displayChlamydiaproteins as part of their membrane structures. * Recombinant gas vesicles (r-Gv) are readily recognized by human immune sera. * Gv engage TLRs and stimulate proinflammatory cytokines in a peptide-specific manner. * Temporal degradation of Gv in vitro, culminates in antigen display at cell surface. * R-Gv promise to be an ideal multisubunit vaccine display/delivery platform.</description><subject>Antibiotics</subject><subject>Antigens</subject><subject>Cloning</subject><subject>Cytokines</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Gases</subject><subject>Infections</subject><subject>Laboratories</subject><subject>Peptides</subject><subject>Plasmids</subject><subject>Proteins</subject><subject>Sexually transmitted diseases</subject><subject>STD</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqNjctqwzAQAEVpoO7jEwoLPdtdyc-cQ0t7z6G3sLE3iYwspVrF4L9vDvmAnuYwA6PUq8ZCo27ex2KmvreeC4PaFNgWWHZ3KtNdW-am1t29ytA0VV5p_HlQjyIjItalXmdq_-1htikGIBEWmdgnCAc4kQt76hNHSw6OJDCz2N6xXEOgzcnRtAyWbmcYrJwdLUB-gIGdnTkuIIsknp7V6kBO-OXGJ_X2-bHdfOXnGH4vLGk3hkv0V7XTjam7tjJrLP9X_QE2Lk84</recordid><startdate>20120907</startdate><enddate>20120907</enddate><creator>Childs, Tawanna S</creator><creator>Webley, Wilmore C</creator><general>Elsevier Limited</general><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20120907</creationdate><title>In vitro assessment of halobacterial gas vesicles as aChlamydiavaccine display and delivery system</title><author>Childs, Tawanna S ; Webley, Wilmore C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_16258742903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antibiotics</topic><topic>Antigens</topic><topic>Cloning</topic><topic>Cytokines</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Gases</topic><topic>Infections</topic><topic>Laboratories</topic><topic>Peptides</topic><topic>Plasmids</topic><topic>Proteins</topic><topic>Sexually transmitted diseases</topic><topic>STD</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Childs, Tawanna S</creatorcontrib><creatorcontrib>Webley, Wilmore C</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Family Health Database (Proquest)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Childs, Tawanna S</au><au>Webley, Wilmore C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro assessment of halobacterial gas vesicles as aChlamydiavaccine display and delivery system</atitle><jtitle>Vaccine</jtitle><date>2012-09-07</date><risdate>2012</risdate><volume>30</volume><issue>41</issue><spage>5942</spage><pages>5942-</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Highlights * Gas vesicles (Gv) displayChlamydiaproteins as part of their membrane structures. * Recombinant gas vesicles (r-Gv) are readily recognized by human immune sera. * Gv engage TLRs and stimulate proinflammatory cytokines in a peptide-specific manner. * Temporal degradation of Gv in vitro, culminates in antigen display at cell surface. * R-Gv promise to be an ideal multisubunit vaccine display/delivery platform.</abstract><cop>Kidlington</cop><pub>Elsevier Limited</pub><doi>10.1016/j.vaccine.2012.07.038</doi></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2012-09, Vol.30 (41), p.5942
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_journals_1625874290
source ScienceDirect Journals
subjects Antibiotics
Antigens
Cloning
Cytokines
Deoxyribonucleic acid
DNA
Gases
Infections
Laboratories
Peptides
Plasmids
Proteins
Sexually transmitted diseases
STD
title In vitro assessment of halobacterial gas vesicles as aChlamydiavaccine display and delivery system
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A54%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20assessment%20of%20halobacterial%20gas%20vesicles%20as%20aChlamydiavaccine%20display%20and%20delivery%20system&rft.jtitle=Vaccine&rft.au=Childs,%20Tawanna%20S&rft.date=2012-09-07&rft.volume=30&rft.issue=41&rft.spage=5942&rft.pages=5942-&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2012.07.038&rft_dat=%3Cproquest%3E3500158261%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_16258742903%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1625874290&rft_id=info:pmid/&rfr_iscdi=true